| VERASTEM INC. NEW |
| USA |
| Gesundheit |
| US92337C2035 / A3EHM3 |
| 2VSA (Frankfurt) / VSTM (NASDAQ) |
| FRA:2VSA, ETR:2VSA, 2VSA:GR, NASDAQ:VSTM |
| - |
| https://www.verastem.com/ |
|
Verastem Inc. is a biopharmaceutical company that ..
>Volltext.. |
| 503.53 Mio. EUR |
| 462.41 Mio. EUR |
| 11.36 Mio. EUR |
| -135.75 Mio. EUR |
| -204.81 Mio. EUR |
| -3.42 EUR |
| 76.01 Mio. EUR |
| 116.98 Mio. EUR |
| -112.68 Mio. EUR |
| 2.31 |
| 26.95% |
| -144.8% |
| - |
| - |
| - |
| VERASTEM |
| 30.12.25 |